|
Placebo for Pembrolizumab Clinical Trials
1 actively recruiting trial across 1 location
No change since August 2026
Pipeline
Phase 3: 1
Top Sponsors
- Astellas Pharma Global Development, Inc.1
Indications
- Gastroesophageal Junction (GEJ) Adenocarcinoma1
- Gastric Adenocarcinoma1
- Cancer1
Saint Louis Park, Minnesota1 trial
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Metro Minnesota Community Oncology Research Consortium
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.